| | Hang Seng Index | 26.420 HKD | +0.600 | +2.324% | 195.50M | 5.12B | 26.071 (+1.339%) HKD as at 2025/12/30 | | |
| | Hang Seng China Enterprises Index | 93.520 HKD | +2.260 | +2.476% | 42.03M | 3.90B | 92.157 (+1.480%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.610 HKD | +0.220 | +4.082% | 479.95M | 2.66B | 5.464 (+2.680%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.500 HKD | +0.395 | +7.738% | 174.55M | 938.52M | 5.240 (+4.954%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.336 HKD | -0.110 | -7.607% | 446.47M | 609.52M | 1.413 (-5.463%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.756 HKD | -0.084 | -4.565% | 133.69M | 237.83M | 1.802 (-2.564%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.135 HKD | +0.290 | +4.962% | 31.61M | 191.16M | 5.991 (+2.407%) HKD as at 2025/12/30 | | |
| | | 10.510 HKD | +0.090 | +0.864% | 15.14M | 158.75M | 10.466 (+0.417%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index (net total return version) | 12.000 HKD | +0.460 | +3.986% | 9.77M | 115.52M | 11.699 (+2.575%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.700 HKD | +0.215 | +3.920% | 17.82M | 100.40M | 5.555 (+2.610%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 17.120 HKD | +0.970 | +6.006% | 5.75M | 95.99M | 16.139 (+6.077%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.620 HKD | +0.060 | +0.307% | 2.14M | 41.97M | 19.669 (-0.250%) HKD as at 2025/12/30 | | |
| | | 9.345 HKD | +0.140 | +1.521% | 4.05M | 37.73M | 9.263 (+0.881%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 20.500 HKD | +0.080 | +0.392% | 1.41M | 28.87M | 20.595 (-0.460%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 36.140 HKD | +2.640 | +7.881% | 791.90K | 28.09M | 33.185 (+8.906%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 3,126.000 HKD | +14.000 | +0.450% | 6.75K | 21.04M | 398.810 (+0.625%) USD as at 2025/12/29 | | |
| | London Gold Fixing Price | 18.340 CNY | +0.020 | +0.109% | 1.07M | 19.72M | 18.483 (-0.772%) CNY as at 2025/12/30 | | |
| | CSI 300 Index | 54.040 HKD | +0.720 | +1.350% | 301.15K | 16.24M | 53.699 (+0.634%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises Index | 3.516 HKD | +0.116 | +3.412% | 2.99M | 10.36M | 3.426 (+2.621%) HKD as at 2025/12/30 | | |
| | FTSE China A50 Index | 16.570 HKD | +0.200 | +1.222% | 545.17K | 9.02M | 16.490 (+0.488%) HKD as at 2025/12/30 | | |
| | Hang Seng Biotech Index | 14.540 HKD | +0.190 | +1.324% | 613.70K | 8.88M | 14.515 (+0.174%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 26.840 HKD | +0.200 | +0.751% | 318.50K | 8.49M | 26.905 (-0.242%) HKD as at 2025/12/30 | | |
| | CSI 300 Index | 34.880 HKD | +0.180 | +0.519% | 210.40K | 7.31M | 34.743 (+0.394%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend Yield Index | 30.540 HKD | +0.140 | +0.461% | 234.31K | 7.14M | 30.441 (+0.326%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index | 8.270 HKD | +0.270 | +3.375% | 737.00K | 6.06M | 8.263 (+0.086%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.222 HKD | +0.002 | +0.062% | 1.79M | 5.79M | 3.201 (+0.672%) HKD as at 2025/12/30 | | |
| | NASDAQ-100 Index | 4,815.000 HKD | +5.000 | +0.104% | 1.08K | 5.18M | 620.870 (-0.441%) USD as at 2025/12/29 | | |
| | FTSE China A50 Index | 15.320 HKD | +0.200 | +1.323% | 326.21K | 4.98M | 15.286 (+0.221%) HKD as at 2025/12/30 | | |
| | | 10.920 HKD | +0.100 | +0.924% | 442.50K | 4.82M | 10.845 (+0.696%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average | 29.180 HKD | -0.400 | -1.352% | 162.34K | 4.79M | 29.738 (-1.877%) HKD as at 2025/12/30 | | |